243 related articles for article (PubMed ID: 8652829)
21. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
[TBL] [Abstract][Full Text] [Related]
22. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
[TBL] [Abstract][Full Text] [Related]
23. High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia.
Geijtenbeek TB; van Kooyk Y; van Vliet SJ; Renes MH; Raymakers RA; Figdor CG
Blood; 1999 Jul; 94(2):754-64. PubMed ID: 10397743
[TBL] [Abstract][Full Text] [Related]
24. The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells.
Tsuchiya T; Hagihara M; Shimakura Y; Ueda Y; Gansuvd B; Munkhbat B; Inoue H; Tazume K; Kato S; Hotta T
Int J Hematol; 2002 Jan; 75(1):55-62. PubMed ID: 11843292
[TBL] [Abstract][Full Text] [Related]
25. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
[TBL] [Abstract][Full Text] [Related]
26. B-lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting.
Mikhailova E; Itov A; Zerkalenkova E; Roumiantseva J; Olshanskaya Y; Karachunskiy A; Novichkova G; Maschan M; Popov A
Cytometry B Clin Cytom; 2022 Sep; 102(5):353-359. PubMed ID: 35796438
[TBL] [Abstract][Full Text] [Related]
27. TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.
Buske C; Becker D; Feuring-Buske M; Hannig H; Wulf G; Schäfer C; Hiddemann W; Wörmann B
Leukemia; 1997 Mar; 11(3):386-92. PubMed ID: 9067578
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
[TBL] [Abstract][Full Text] [Related]
29. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
le Viseur C; Hotfilder M; Bomken S; Wilson K; Röttgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jürgens H; Schrappe M; Pieters R; Vormoor J
Cancer Cell; 2008 Jul; 14(1):47-58. PubMed ID: 18598943
[TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
31. Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.
Fabricius D; Breckerbohm L; Vollmer A; Queudeville M; Eckhoff SM; Fulda S; Strauss G; Debatin KM; Jahrsdörfer B; Meyer LH
Leukemia; 2011 Jul; 25(7):1111-21. PubMed ID: 21527935
[TBL] [Abstract][Full Text] [Related]
32. Diminished expression of CD40 ligand by activated neonatal T cells.
Nonoyama S; Penix LA; Edwards CP; Lewis DB; Ito S; Aruffo A; Wilson CB; Ochs HD
J Clin Invest; 1995 Jan; 95(1):66-75. PubMed ID: 7814647
[TBL] [Abstract][Full Text] [Related]
33. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions.
Denépoux S; Fournier N; Péronne C; Banchereau J; Lebecque S
J Immunol; 2000 Feb; 164(3):1306-13. PubMed ID: 10640744
[TBL] [Abstract][Full Text] [Related]
34. T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy.
D'Amico G; Bonamino M; Dander E; Marin V; Basso G; Balduzzi A; Biagi E; Biondi A
Leukemia; 2006 Nov; 20(11):2015-24. PubMed ID: 16990769
[TBL] [Abstract][Full Text] [Related]
35. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations.
Dworzak MN; Fritsch G; Fleischer C; Printz D; Fröschl G; Buchinger P; Mann G; Gadner H
Exp Hematol; 1998 Apr; 26(4):305-13. PubMed ID: 9546313
[TBL] [Abstract][Full Text] [Related]
36. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
37. In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines.
Bruserud Ø; Glenjen N; Ryningen A; Ulvestad E
Leuk Res; 2003 May; 27(5):455-64. PubMed ID: 12620297
[TBL] [Abstract][Full Text] [Related]
38. Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Lymphoma; 1999 Nov; 35(5-6):513-26. PubMed ID: 10609789
[TBL] [Abstract][Full Text] [Related]
39. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
[TBL] [Abstract][Full Text] [Related]
40. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.
Funakoshi S; Taub DD; Anver MR; Raziuddin A; Asai O; Reddy V; Rager H; Fanslow WC; Longo DL; Murphy WJ
J Clin Invest; 1997 Feb; 99(3):484-91. PubMed ID: 9022082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]